Surcharges en fer secondaires

Annales de Biologie Clinique

Volumn 56, Issue SPEC. ISS. 2, 1998, Pages 44-48

  Galacteros, F ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; FERRITIN; IRON;

ADULT; BLOOD; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; COMPARATIVE STUDY; CONGENITAL DYSERYTHROPOIETIC ANEMIA; DIFFERENTIAL DIAGNOSIS; HEMOLYTIC ANEMIA; HUMAN; INTESTINE ABSORPTION; IRON OVERLOAD; METABOLISM; PROGNOSIS; REVIEW;

ADULT; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; ANEMIA, HEMOLYTIC; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; CHELATING AGENTS; DEFEROXAMINE; DIAGNOSIS, DIFFERENTIAL; FERRITINS; HUMANS; INTESTINAL ABSORPTION; IRON; IRON OVERLOAD; PROGNOSIS;

EID: 0032128706     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Schafer AL, Cheron RG, Dluhy R, et al. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981; 304: 319-24.
2. Erlandson ME, Walden B, Stern G. Hilgartner MW, Wehman J, Smith CH. Studies on congenital hemolytic syndromes. IV. Gastrointestinal absorption of iron. Blood 1962; 19: 359-78.
3. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption and loading in beta-thalassaemia intermedia. Lancet 1979; ii: 81-21.
4. Pootrakul P, Kitcharoen P, Yansukon P, et al. The effect of erythroid hyperplasia on iron balance. Blood 1988; 71: 1124-9.
5. +) absorption, hypoxia and erythropoiesis in the mouse. Br J Haematol 1988; 68: 373-8.
6. +) absorption in mice. Br J Haematol 1989; 73: 254-9.
7. Skikne RS, Cook JD. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992; 20: 746-51.
8. Gordeuk VR. Hereditary and nutritional iron overload. Baillière's Clin Haematol 1992; 5: 169-86.
9. Eschbach JW, Cook JD, Scribner BH, Finch CA. Iron balance in hemodialysis patients. Ann Inter Med 1977; 87: 710-3.
10. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end stage renal disease with recombinant human erythropoietin : results of a combined phase I and II clinical trial. N Engl J Med 1987; 316: 73-8.
11. Cazzola M, Barosi G, Bergamaschi G, et al. Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol 1983; 54: 649-54.
12. Greiner TC, Burns CP, Dick FR, Henry KM, Mahmood I. Congenital dyserythropoietic anemia type 11 diagnosed in a 69 year old patient with iron overload. Am J Clin Pathol 1992; 98: 522-5.
13. Carvill I, Ricketts C, Jacobs A, Letsky E. Erythropoiesis and the effect of transfusion in homozygous β-thalassemia. N Engl J Med 1978; 298: 776-8.
14. Zurlo MG, Destefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet 1989; i: 27-30.
15. Cazzola M, Barosi G, Gobbi PG, Invernizzi R, Riccardi A, Ascarie E. Natural history of idiopathic refractory sideroblastic anemia. Blood 1998; 71: 305-12.
16. Irving MG, Halliday JW, Powell LW. Association between alcoholism and increased hepatic iron stores. Alcoholism 1988; 12: 7-13.
17. Cohen A, Cohen IJ, Schwartz E. Scurvy and altered iron stores in thalassemia major. N Engl J Med 1981; 304: 158-60.
18. Lipschitz DA, Bothwell TH, Seftel HC, Wapnick AA, Charlton RW. The role of ascorbic acid in the metabolism of storage iron. Br J Haematol 1971; 20: 155-63.
19. Roeser HP. The role of ascorbic acid in the turnover of storage iron. Semin Hematol 1983; 20: 91-100.